GHSI Guardion Health Sciences

Guardion Provides Update on Strategy, Business Plans and Initiatives

Guardion Provides Update on Strategy, Business Plans and Initiatives
EN
05/10/2020

Underlying

GHSIGuardion Health Sciences

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Guardion Health Sciences

 PRESS RELEASE
Free
GHSI Guardion Health...

Guardion Health Sciences Announces Financial Results for the Three Mon...

Guardion Health Sciences Announces Financial Results for the Three Months and Six Months Ended June 30, 2023 Viactiv® Product Line Total Revenue Increased Approximately 6% for the Six Months Ended June 30, 2023, as Compared to the Six Months Ended June 30, 2022; Robust Growth in Amazon Sales Channel Demonstrates Positive Results of Company’s Focus on eCommerce Initiatives HOUSTON, Aug. 14, 2023 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”), a clinical nutrition company that offers a portfolio of science-based, clinically-supported produc...

August 14, 2023 1 EN
 PRESS RELEASE
Free
GHSI Guardion Health...

Guardion Health Sciences Announces Appointment of Former Neutrogena an...

Guardion Health Sciences Announces Appointment of Former Neutrogena and Coca-Cola Executive Jan Hall as President and Chief Executive Officer Former President and Chief Executive Officer Bret Scholtes Resigning to Pursue Other Business Opportunities HOUSTON, May 30, 2023 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”), a clinical nutrition company that offers a portfolio of science-based, clinically-supported products designed to support the health needs of consumers, healthcare professionals and providers and their patients, announced tha...

May 30, 2023 1 EN
 PRESS RELEASE
Free
GHSI Guardion Health...

Guardion Health Sciences Announces Financial Results for the Quarter E...

Guardion Health Sciences Announces Financial Results for the Quarter Ended March 31, 2023 Viactiv® Product Line Total Revenue Increased approximately 37% for the Quarter Ended March 31, 2023 as compared to the Quarter Ended March 31, 2022 HOUSTON, May 15, 2023 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”), a clinical nutrition company that offers a portfolio of science-based, clinically-supported products designed to support the health needs of consumers, healthcare professionals and providers and their patients, announced its financial ...

May 15, 2023 1 EN
 PRESS RELEASE
Free
GHSI Guardion Health...

Guardion Health Sciences Announces Financial Results for the Year Ende...

Guardion Health Sciences Announces Financial Results for the Year Ended December 31, 2022 Viactiv® Product Line Generated Net Revenues of approximately $10.6 Million or 96% of Net Revenues for the Year Ended December 31, 2022 HOUSTON, April 17, 2023 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”), a clinical nutrition company that offers a portfolio of science-based, clinically-supported products designed to support the health needs of consumers, healthcare professionals and providers and their patients, announced its financial results for...

April 17, 2023 1 EN
 PRESS RELEASE
Free
GHSI Guardion Health...

Guardion Health Sciences Hires Alantra, LLC as its Financial Advisor t...

Guardion Health Sciences Hires Alantra, LLC as its Financial Advisor to Explore Strategic Alternatives to Maximize Stockholder Value Alantra, LLC is an experienced and successful international healthcare investment banking firm HOUSTON, March 06, 2023 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”), a clinical nutrition company that offers a portfolio of science-based, clinically-supported products designed to support the health needs of consumers, healthcare professionals and providers and their patients, has retained Alantra, LLC (“Alant...

March 6, 2023 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch